“Anthropic filed an S-1 and for those of us in the biotech space, there's a surprising amount of language highlighting life sciences as sort of an explicit strategic expansion for the company… They're sort of talking about not just helping with their AI capabilities with companies that are in the development space but actually moving into drug development themselves.”

…the great things that company has done but it also shows that um you can get a lot of accolades when you uh generate positive clinical data but uh when you uh try to launch your own drug um uh the rubber kind of hits the road and so a little bit of commercial challenges there for uh for al nylum

…about that you know beyond their their current franchise um so look ai it's hard to go through any week without ai being a big topic in biotech but this one uh kind of an unprecedented deal that was done by anthropic brian you want to kick us off on that and it might lead to a broader discussion

context around this because i think this conversation is reaching fever pitch, right? It seems. And just a few like almost blog posts that have happened this week. So first, this morning, Bruce Booth posted a really nice article. Again, I'd say old guard perspective on how, Brian, to your point…

Well, in our chat, I think Sam brought up a very provocative question. And I think AI is absolutely going to make a difference. And I think eventually people are going to have a lot more free time because they are going to be in their self-driving Tesla on the way to work. And it's going to make…

So look, we in my team use AI quite a bit. And I can verify that for some relatively basic tasks where I need massive amounts of data gathered and sifted through, it is making a significant difference. I'm finding that I can displace two or three contractors, for instance, in some data gathering…